-
1دورية أكاديمية
المؤلفون: Harrington, KJ, Cohen, EEW, Soulières, D, Dinis, J, Licitra, L, Ahn, M-J, Soria, A, Machiels, J-P, Mach, N, Mehra, R, Burtness, B, Swaby, RF, Lin, J, Ge, J, Lerman, N, Tourneau, CL
المساهمون: Harrington, Kevin
مصطلحات موضوعية: Head and neck squamous cell carcinoma, Metastatic, Pembrolizumab, Recurrent, Humans, Squamous Cell Carcinoma of Head and Neck, Cetuximab, Docetaxel, Methotrexate, Platinum, Neoplasm Recurrence, Local, Head and Neck Neoplasms, Antineoplastic Combined Chemotherapy Protocols
جغرافية الموضوع: England
وصف الملف: Print-Electronic; application/pdf
العلاقة: ARTN 106587; S1368-8375(23)00283-X; Oral Oncology, 2023, 147 pp. 106587 -; https://repository.icr.ac.uk/handle/internal/6134Test
الإتاحة: https://doi.org/10.1016/j.oraloncology.2023.106587Test
https://repository.icr.ac.uk/handle/internal/6134Test -
2دورية أكاديمية
المؤلفون: Harrington, K.J., Cohen, E.E.W., Soulières, D., Dinis, J., Licitra, L., Ahn, M.-J., Soria, A., Machiels, J.-P., Mach, N., Mehra, R., Burtness, B., Swaby, R.F., Lin, J., Ge, J., Lerman, N., Tourneau, C. Le
المصدر: Oral Oncology ; volume 147, page 106587 ; ISSN 1368-8375
مصطلحات موضوعية: Cancer Research, Oncology, Oral Surgery
الإتاحة: https://doi.org/10.1016/j.oraloncology.2023.106587Test
https://api.elsevier.com/content/article/PII:S136883752300283X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S136883752300283X?httpAccept=text/plainTest -
3مؤتمر
المؤلفون: Soulieres, D., Harrington, K.j., Le Tourneau, C., Silva, J.d., Licitra, L.f., Ahn, M-J., Soria, A., Machiels, J-P., Mach, Nicolas, Mehra, R., Burtness, B., Lin, J., Lerman, N., Gumuscu, B., Cohen, E.e.w.
المصدر: European Society for Medical Oncology (ESMO) Congress, (2022)
مصطلحات موضوعية: info:eu-repo/classification/ddc/616
العلاقة: https://archive-ouverte.unige.ch/unige:175805Test; unige:175805
-
4دورية أكاديمية
المؤلفون: Rischin, D, Harrington, KJ, Greil, R, Soulieres, D, Tahara, M, de Castro Jr, G, Psyrri, A, Brana, I, Neupane, P, Bratland, A, Fuereder, T, Hughes, BGM, Mesia, R, Ngamphaiboon, N, Rordorf, T, Ishak, WZW, Hong, R-L, Mendoza, RG, Jia, L, Chirovsky, D, Norquist, J, Jin, F, Burtness, B
العلاقة: pii: S1368-8375(22)00104-X; Rischin, D., Harrington, K. J., Greil, R., Soulieres, D., Tahara, M., de Castro Jr, G., Psyrri, A., Brana, I., Neupane, P., Bratland, A., Fuereder, T., Hughes, B. G. M., Mesia, R., Ngamphaiboon, N., Rordorf, T., Ishak, W. Z. W., Hong, R. -L., Mendoza, R. G., Jia, L. ,. Burtness, B. (2022). Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048. ORAL ONCOLOGY, 128, https://doi.org/10.1016/j.oraloncology.2022.105815Test.; http://hdl.handle.net/11343/310620Test
-
5دورية أكاديمية
المؤلفون: Burtness, B, Rischin, D, Greil, R, Soulieres, D, Tahara, M, de Castro Jr, G, Psyrri, A, Brana, I, Baste, N, Neupane, P, Bratland, A, Fuereder, T, Hughes, BGM, Mesia, R, Ngamphaiboon, N, Rordorf, T, Wan Ishak, WZ, Ge, J, Swaby, RF, Gumuscu, B, Harrington, K
العلاقة: Burtness, B., Rischin, D., Greil, R., Soulieres, D., Tahara, M., de Castro Jr, G., Psyrri, A., Brana, I., Baste, N., Neupane, P., Bratland, A., Fuereder, T., Hughes, B. G. M., Mesia, R., Ngamphaiboon, N., Rordorf, T., Wan Ishak, W. Z., Ge, J., Swaby, R. F. ,. Harrington, K. (2022). Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score. JOURNAL OF CLINICAL ONCOLOGY, 40 (21), pp.2321-+. https://doi.org/10.1200/JCO.21.02198Test.; http://hdl.handle.net/11343/307776Test
-
6دورية أكاديمية
المؤلفون: Harrington, KJ, Burtness, B, Greil, R, Soulières, D, Tahara, M, de Castro, G, Psyrri, A, Brana, I, Basté, N, Neupane, P, Bratland, Å, Fuereder, T, Hughes, BGM, Mesia, R, Ngamphaiboon, N, Rordorf, T, Wan Ishak, WZ, Lin, J, Gumuscu, B, Swaby, RF, Rischin, D
المساهمون: Harrington, Kevin
جغرافية الموضوع: United States
وصف الملف: Print-Electronic; application/pdf
العلاقة: Journal of Clinical Oncology, 2022, pp. JCO2102508 -; https://repository.icr.ac.uk/handle/internal/5625Test
الإتاحة: https://doi.org/10.1200/JCO.21.02508Test
https://repository.icr.ac.uk/handle/internal/5625Test -
7دورية أكاديمية
المؤلفون: Bou-Nehme Sawaya, G, Dragomir, A, Kollmannsberger, C, Basappa, NS, Kapoor, A, Soulières, D, Finelli, A, Heng, DYC, Wood, L, Castonguay, V, Canil, C, Winquist, E, Graham, J, Bjarnason, GA, Bhindi, B, Lalani, AK, Pouliot, F, Breau, RH, Tanguay, S
المصدر: Value in Health ; volume 25, issue 12, page S39 ; ISSN 1098-3015
مصطلحات موضوعية: Public Health, Environmental and Occupational Health, Health Policy
الإتاحة: https://doi.org/10.1016/j.jval.2022.09.186Test
https://api.elsevier.com/content/article/PII:S1098301522023907?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1098301522023907?httpAccept=text/plainTest -
8دورية أكاديمية
المؤلفون: Tahara, M., Greil, R., Rischin, D., Harrington, K.J., Burtness, B., De Castro, G., Psyrri, A., Brana, I., Neupane, P., Bratland, Å., Fuereder, T., Hughes, B.G.M., Mesia Nin, R., Ngamphaiboon, N., Rordorf, T., Wan Ishak, W.Z., Lin, J., Gumuscu, B., Lerman, N., Soulieres, D.
المصدر: Annals of Oncology ; volume 33, page S844 ; ISSN 0923-7534
مصطلحات موضوعية: Oncology, Hematology
الإتاحة: https://doi.org/10.1016/j.annonc.2022.07.783Test
https://api.elsevier.com/content/article/PII:S0923753422026345?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753422026345?httpAccept=text/plainTest -
9دورية أكاديمية
المؤلفون: Gafanov, R., Powles, T.B., Bedke, J., Stus, V., Waddell, T.S., Nosov, D., Pouliot, F., Soulieres, D., Melichar, B., Azevedo, S., McDermott, R.S., Vynnychenko, I.O., Borchiellini, D., Markus, M., Bondarenko, I., Lin, J., Burgents, J., Molife, L.R., Plimack, E.R., Rini, B.
المصدر: Annals of Oncology ; volume 32, page S694 ; ISSN 0923-7534
مصطلحات موضوعية: Oncology, Hematology
الإتاحة: https://doi.org/10.1016/j.annonc.2021.08.065Test
https://api.elsevier.com/content/article/PII:S0923753421022791?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753421022791?httpAccept=text/plainTest -
10مؤتمر
المؤلفون: Rini, B. I., Plimack, E. R., Stus, V., Gafanov, R., Waddell, Thomas, Nosov, D., Pouliot, F., Alekseev, B., Soulieres, D., Melichar, B., Vynnychenko, I. O., Azevedo, S. J., Borchiellini, D., McDermott, R. S., Bedke, J., Tamada, S., Wu, S., Burgents, J., Molife, L. R., Powles, T.
المساهمون: Vanderbilt-Ingram Cancer Center, Nashville, TN
العلاقة: https://doi.org/10.1200/JCO.2023.41.17_suppl.LBA4501Test; Rini BI, Plimack ER, Stus V, Gafanov R, Waddell T, Nosov D, et al. Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma: 5-year analysis of KEYNOTE-426. Journal of Clinical Oncology. 2023 Jun;41(17). PubMed PMID: WOS:001043181100025.; http://hdl.handle.net/10541/626581Test; Journal of Clinical Oncology
الإتاحة: https://doi.org/10.1200/JCO.2023.41.17_suppl.LBA4501Test
http://hdl.handle.net/10541/626581Test
